The FDA has doled out two manufacturing-related complete response letters (CRLs), slamming the brakes on prospective ...

CINCINNATI (WKRC)— A newer trend in Botox and fillers is gaining popularity for its dual benefits, addressing both cosmetic concerns and medical conditions. Nurse Practitioner Donna Abdelnour from the ...

AbbVie ABBV has built a substantial neuroscience franchise. While the segment was initially anchored by Botox Therapeutic and the depression drug Vraylar, its offerings now include the oral migraine ...

ABBV eyes a strong Q1 performance as neuroscience sales, led by Botox and Vraylar, are set to jump 22%, with newer drugs ...